SCHEMBL4524808

SCHEMBL4524808

CC(C)C1N(C(=O)c2ccc3c(c2)nnn3C)C=C(C(=O)O)c2[nH]c3ccccc3c2C1(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 2/20 0.43
ALDH1A1 P00352 1/20 0.42
RAB9A P51151 3/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PKM P14618 1/20 0.40
HPGD P15428 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NR1H4 Q96RI1 2/20 0.38
ESR1 P03372 1/20 0.38
NR3C1 P04150 1/20 0.38
PGR P06401 1/20 0.38
NR3C2 P08235 1/20 0.38
AR P10275 1/20 0.38
HSD11B1 P28845 2/20 0.37
POLB P06746 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 2/20 0.36
AHR P35869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4536933 0.84 NR1H4 (0.40) MEN1KMT2ANR1H4ESR1NR3C1
SCHEMBL1242997 0.83 NR1H4 (0.54) NR1H4ESR1NR3C1PGRNR3C2
SCHEMBL4526049 0.79 MAPT (0.43) KMT2ANR1H4ESR1NR3C1PGR
SCHEMBL4527800 0.79 NR1H4 (0.41) NR1H4ESR1NR3C1PGRNR3C2
SCHEMBL4513774 0.79 NR1H4 (0.42) NR1H4ESR1NR3C1PGRNR3C2
SCHEMBL4526382 0.78 NR1H4 (0.43) NR1H4ESR1NR3C1PGRNR3C2
SCHEMBL4533951 0.78 NR1H4 (0.42) NR1H4ESR1NR3C1PGRNR3C2
SCHEMBL4529782 0.77 GAA (0.41) MEN1KMT2APKMNR1H4ESR1
SCHEMBL4532271 0.77 NR1H4 (0.42) NR1H4ESR1NR3C1PGRNR3C2
SCHEMBL4530734 0.77 NR1H4 (0.42) NR1H4ESR1NR3C1PGRNR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203577-A1 Azepinoindole Derivatives As Pharmaceutical Agents EXELIXIS, INC. (US) 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203577-A1 Azepinoindole Derivatives As Pharmaceutical Agents NR1H4, NR1I2, GPBAR1 HCAR3 372/4885ALDH1A1 622/4885RAB9A 2121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.